DBTX vs MXCT
Comparison between Decibel Therapeutics Inc (DBTX, Company) and MaxCyte Inc (MXCT, Company).
DBTX vs MXCT - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
DBTX
$123M
MXCT
$122M
Max Drawdown
Winner
DBTX
90.70%
MXCT
96.07%
Sharpe Ratio
Winner
DBTX
0.64
MXCT
-0.61
5Y Beta
DBTX
N/A
MXCT
1.32
Industry
DBTX
N/A
MXCT
Medical Devices
P/E Ratio
DBTX
-1.94
Winner
MXCT
-3.11
5Y EPS CAGR
DBTX
N/A
MXCT
12.02%
Debt to Equity
DBTX
0.18%
Winner
MXCT
0.00%
Free Cash Flow Yield
DBTX
-40.16%
Winner
MXCT
-24.04%
P/S Ratio
DBTX
N/A
MXCT
3.78
P/B Ratio
DBTX
2.30
Winner
MXCT
0.78
DBTX vs MXCT - Historical Returns
Returns include dividend reinvestment.
1M
Winner
DBTX
-4.47%
MXCT
-4.68%
3M
DBTX
+22.75%
Winner
MXCT
+29.99%
6M
Winner
DBTX
+85.28%
MXCT
-3.45%
1Y
Winner
DBTX
+24.30%
MXCT
-51.93%
5Y(CAGR)
DBTX
N/A
MXCT
-28.16%
Max(CAGR)
DBTX
-39.19%
Winner
MXCT
-5.18%
DBTX vs MXCT - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | DBTX | MXCT |
|---|---|---|
| 2026 | N/A | -27.74% |
| 2025 | N/A | -62.65% |
| 2024 | N/A | -16.80% |
| 2023 | +136.63% | -8.20% |
| 2022 | -59.24% | -49.63% |
| 2021 | -74.21% | +525.15% |
| 2020 | N/A | +0.00% |
| 2019 | N/A | +2.31% |
DBTX vs MXCT Drawdown Comparison
The maximum drawdown for DBTX was -90.70%, occurring on May 9, 2022. This drawdown has not yet recovered.
The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current DBTX drawdown is -75.33%. The current MXCT drawdown is -93.49%.
| Rank | DBTX | MXCT |
|---|---|---|
| #1 | -90.70% Feb 22, 2021 - May 9, 2022 | -96.07% Sep 3, 2021 - Mar 30, 2026 |
| #2 | N/A | -37.58% Jan 22, 2021 - Jul 30, 2021 |
| #3 | N/A | -19.65% Jul 30, 2021 - Sep 3, 2021 |
Correlation
Correlation between DBTX and MXCT is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.40
-101
Select Stocks to Compare
Popular: DBTX vs SPYMXCT vs SPY
More Comparisons
Compare with similar stocks